|
⚲
|
| Keyboard |
| Luo Ying
✚
|
|
|---|---|
| CIK # | 0001959160 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001959160] | |
| 4 | [0001959160] | |
| SC 13D | [0001959160] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| LUO Ying | GYRE Therapeutics Inc | [2024-09-06] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Luo Ying | |
| GYRE Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2024-08-14 | Grant | 26,000 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2023-11-20 | Grant | 2,262,755 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2023-11-20 | Grant | 3,350,897 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2023-10-31 | Grant | 1,866 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2023-10-30 | Other | 2,840,376 |